Kexing Biopharm Co., Ltd.SSE: 688136

Announcement on General Election of Board of Directors

Jul 29, 2025 · Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 29, 2025

On 6ix: 6ix.com/news/announcement-on-general-election-of-board-of-directors

Announcement on Election of Board of Directors at Expiry of Term of Office

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Kexing Biopharm Co., Ltd. on 6ix

Earlier from Kexing Biopharm

Announcement on Vesting Results and Share Listing in the 1st Vesting Period of the 2024 Restricted Stock Incentive PlanJul 11, 2025
Announcement on Shareholding Changes Reaching 1% Threshold, Completion of Shareholding Reduction Plan and Results of Shares SoldJul 10, 2025
Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in ShanghaiJul 4, 2025
Announcement on Abnormal Fluctuations in Stock TradingJul 4, 2025
Announcement on the Progress of Proposed Transfer of Equity of Wholly-owned SubsidiaryJul 3, 2025

Later from Kexing Biopharm

Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 1% Integer MultipleAug 6, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025Aug 12, 2025
BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and PakistanAug 13, 2025
Announcement on Signing a Supplementary Agreement to Agreement of Related Party TransactionsAug 16, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025Aug 23, 2025

All Kexing Biopharm news releases

Follow Kexing Biopharm into a list and get an email when it puts out news.

Follow Kexing Biopharm